Goldenwell Biotech Files 2024 10-K
Ticker: GWLL · Form: 10-K · Filed: May 15, 2025 · CIK: 1800373
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
GDWL 10-K filed. Full year 2024 financials out. Check it.
AI Summary
Goldenwell Biotech, Inc. filed its 2024 10-K on May 15, 2025, reporting its fiscal year ending December 31, 2024. The company, incorporated in Nevada and headquartered in Hudson, Ohio, operates within the Food & Kindred Products sector. Key financial details and business operations for the period are outlined in the filing.
Why It Matters
This filing provides a comprehensive overview of Goldenwell Biotech's financial performance and business activities for the fiscal year 2024, crucial for investors and stakeholders to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — The provided text is a standard 10-K filing header and does not contain specific risk factors or operational details that would indicate a high or medium risk level.
Key Numbers
- 300000000 — Authorized Shares (Indicates the maximum number of shares the company is legally allowed to issue.)
- 99000000 — Common Stock Value (Represents the par value of common stock outstanding as of fiscal year end 2024.)
- 99000000 — Additional Paid-In Capital (Amount received from shareholders in excess of par value for stock issued as of fiscal year end 2024.)
- 99000000 — Retained Earnings (Accumulated profits of the company not distributed as dividends as of fiscal year end 2024.)
Key Players & Entities
- GOLDENWELL BIOTECH, INC. (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 20250515 (date) — Filing Date
- 581 BOSTON MILLS ROAD, SUITE 300 (address) — Business Address
- HUDSON, OH 44236 (address) — Business Address City, State, Zip
- 440-666-7999 (phone_number) — Business Phone
- MegalightIncMember (company) — Related Entity
FAQ
What is Goldenwell Biotech, Inc.'s primary business sector?
Goldenwell Biotech, Inc. operates within the FOOD & KINDRED PRODUCTS sector, SIC code 2000.
When did Goldenwell Biotech, Inc. file its 2024 10-K?
The 10-K filing was made on May 15, 2025.
What is the company's principal executive office address?
The company's business address is 581 BOSTON MILLS ROAD, SUITE 300, HUDSON, OH 44236.
What was the fiscal year end for this 10-K filing?
The fiscal year end reported in this 10-K filing is December 31, 2024.
What is the Central Index Key (CIK) for Goldenwell Biotech, Inc.?
The Central Index Key for Goldenwell Biotech, Inc. is 0001800373.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on May 15, 2025 regarding GOLDENWELL BIOTECH, INC. (GWLL).